A phase I study of ruxolitinib in combination with abemaciclib for patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis

被引：0
|
作者：
Bewersdorf, Jan Philipp
Verstovsek, Srdan
Derkach, Andriy
Masarova, Lucia
Pemmaraju, Naveen
Stein, Eytan M.
Mauro, Michael J.
Rampal, Raajit
Bose, Prithviraj
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS7086
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
    Mora, Barbara
    Giorgino, Toni
    Guglielmelli, Paola
    Rumi, Elisa
    Maffioli, Margherita
    Rambaldi, Alessandro
    Caramella, Marianna
    Komrokji, Rami
    Gotlib, Jason
    Kiladjian, Jean Jacques
    Cervantes, Francisco
    Devos, Timothy
    Palandri, Francesca
    De Stefano, Valerio
    Ruggeri, Marco
    Silver, Richard T.
    Benevolo, Giulia
    Albano, Francesco
    Cavalloni, Chiara
    Barraco, Daniela
    Merli, Michele
    Pietra, Daniela
    Casalone, Rosario
    Barbui, Tiziano
    Rotunno, Giada
    Cazzola, Mario
    Vannucchi, Alessandro Maria
    Passamonti, Francesco
    HAEMATOLOGICA, 2018, 103 (09) : E392 - E394
  • [32] A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis
    Andersen, Christen L.
    Mortensen, Nana B.
    Klausen, Tobias W.
    Vestergaard, Hanne
    Bjerrum, Ole W.
    Hasselbalch, Hans C.
    HAEMATOLOGICA, 2014, 99 (01)
  • [33] The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF)
    McMullin, Mary Frances
    Harrison, Claire N.
    Niederwieser, Dietger
    Demuynck, Hilde
    Jakel, Nadja
    Sirulnik, Andres
    McQuity, Mari
    Stalbovskaya, Viktoriya
    Recher, Christian
    Theunissen, Koen
    Gisslinger, Heinz
    Kiladjian, Jean-Jacques
    Al-Ali, Haifa-Kathrin
    BLOOD, 2012, 120 (21)
  • [34] Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
    Murata, Makoto
    Suzuki, Ritsuro
    Nishida, Tetsuya
    Shirane, Shuichi
    Shimazu, Yutaka
    Minami, Yosuke
    Mori, Takehiko
    Doki, Noriko
    Kanda, Yoshinobu
    Uchida, Naoyuki
    Tanaka, Masatsugu
    Ishikawa, Jun
    Togitani, Kazuto
    Fukuda, Takahiro
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Nagamura-Inoue, Tokiko
    Kiyoi, Hitoshi
    INTERNAL MEDICINE, 2020, 59 (16) : 1947 - 1956
  • [35] Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
    Kotaro Shide
    Katsuto Takenaka
    Akira Kitanaka
    Akihiko Numata
    Takuro Kameda
    Takuji Yamauchi
    Atsushi Inagaki
    Shohei Mizuno
    Akiyoshi Takami
    Shinichi Ito
    Masao Hagihara
    Kensuke Usuki
    Takaaki Maekawa
    Kazutaka Sunami
    Yasunori Ueda
    Miyuki Tsutsui
    Miki Ando
    Norio Komatsu
    Keiya Ozawa
    Mineo Kurokawa
    Shunya Arai
    Kinuko Mitani
    Koichi Akashi
    Kazuya Shimoda
    Annals of Hematology, 2024, 103 : 97 - 103
  • [36] Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
    Shide, Kotaro
    Takenaka, Katsuto
    Kitanaka, Akira
    Numata, Akihiko
    Kameda, Takuro
    Yamauchi, Takuji
    Inagaki, Atsushi
    Mizuno, Shohei
    Takami, Akiyoshi
    Ito, Shinichi
    Hagihara, Masao
    Usuki, Kensuke
    Maekawa, Takaaki
    Sunami, Kazutaka
    Ueda, Yasunori
    Tsutsui, Miyuki
    Ando, Miki
    Komatsu, Norio
    Ozawa, Keiya
    Kurokawa, Mineo
    Arai, Shunya
    Mitani, Kinuko
    Akashi, Koichi
    Shimoda, Kazuya
    ANNALS OF HEMATOLOGY, 2024, 103 (01) : 97 - 103
  • [37] A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis
    Quintas-Cardama, A.
    Tong, W.
    Kantarjian, H.
    Thomas, D.
    Ravandi, F.
    Kornblau, S.
    Manshouri, T.
    Cortes, J. E.
    Garcia-Manero, G.
    Verstovsek, S.
    LEUKEMIA, 2008, 22 (05) : 965 - 970
  • [38] A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis
    A Quintás-Cardama
    W Tong
    H Kantarjian
    D Thomas
    F Ravandi
    S Kornblau
    T Manshouri
    J E Cortes
    G Garcia-Manero
    S Verstovsek
    Leukemia, 2008, 22 : 965 - 970
  • [39] Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
    Santos, Fabio P. S.
    Kantarjian, Hagop M.
    Jain, Nitin
    Manshouri, Taghi
    Thomas, Deborah A.
    Garcia-Manero, Guillermo
    Kennedy, Debra
    Estrov, Zeev
    Cortes, Jorge
    Verstovsek, Srdan
    BLOOD, 2010, 115 (06) : 1131 - 1136
  • [40] CYTOGENETIC ABNORMALITIES IN POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: CORRELATIONS WITH GENOTYPE AND PHENOTYPE IN THE MYSEC STUDY
    Mora, B.
    Giorgino, T.
    Guglielmelli, P.
    Rumi, E.
    Maffioli, M.
    Rambaldi, A.
    Caramella, M.
    Komrokji, R.
    Gotlib, J.
    Kiladjian, J. J.
    Cervantes, F.
    Devos, T.
    Palandri, F.
    De Stefano, V.
    Ruggeri, M.
    Silver, R. T.
    Benevolo, G.
    Albano, F.
    Caramazza, D.
    Merli, M.
    Pietra, D.
    Casalone, R.
    Barbui, T.
    Rotunno, G.
    Cazzola, M.
    Vannucchi, A. M.
    Passamonti, F.
    HAEMATOLOGICA, 2017, 102 : 3 - 4
12345